AVXS Overview
Upcoming Projects (AVXS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AVXS)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (AVXS)
-
Comparing Biogen's recently approved Spinraza to AveXis' pipeline drug AVXS-101 in treating spinal muscular atrophy
Tickers: BIIB, AVXS
Execute By: Aug 15, 2017
Upcoming & Overdue Catalysts (AVXS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AVXS)
-
AveXis (AVXS) Reports Topline Results from Phase 1 Trial of AVXS-101 in SMA Type 1
Ticker: AVXS
Occurred on: Mar 16, 2017 -
Pivotal trials of AVXS-101 for SMA Type 1 expected to initiate in the first half of 2017
Ticker: AVXS
Occurred on: Feb 06, 2017 -
AveXis Receives U.S. FDA Breakthrough Therapy Designation for AVXS-101 Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
Ticker: AVXS
Occurred on: Jul 20, 2016 -
AveXis is set for its IPO of 4.25M shares of common stock at $19 - 21
Ticker: AVXS
Occurred on: Feb 08, 2016
Strategic Initiatives (AVXS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
